127 related articles for article (PubMed ID: 5656653)
1. Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase.
Bagshawe KD; Currie GA
Nature; 1968 Jun; 218(5148):1254-5. PubMed ID: 5656653
[No Abstract] [Full Text] [Related]
2. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
Sethi KK; Brandis H
Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
[No Abstract] [Full Text] [Related]
3. Neuraminidase induced loss in the transplantability of murine leukaemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA-2 mice by serum and peritoneal cells.
Sethi KK; Brandis H
Br J Cancer; 1973 Feb; 27(2):106-13. PubMed ID: 4348470
[TBL] [Abstract][Full Text] [Related]
4. Interaction of syngeneic, allogeneic and xenogeneic complement with murine leukaemia and carcinoma cells in vitro [proceedings].
Peeters P; Verloes R; Atassi G; Kanarek L
Arch Int Physiol Biochim; 1979 Oct; 87(4):836-8. PubMed ID: 93935
[No Abstract] [Full Text] [Related]
5. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment.
Bekesi JG; St-Arneault G; Holland JF
Cancer Res; 1971 Dec; 31(12):2130-2. PubMed ID: 5120303
[No Abstract] [Full Text] [Related]
6. Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
Bekesi JG; St Arneault G; Walter L; Holland JF
J Natl Cancer Inst; 1972 Jul; 49(1):107-18. PubMed ID: 4338766
[No Abstract] [Full Text] [Related]
7. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
[No Abstract] [Full Text] [Related]
8. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia.
Bekesi JG; Roboz JP; Holland JF
Ann N Y Acad Sci; 1976; 277(00):313-31. PubMed ID: 1069551
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxic effect of macrophages and normal mouse serum on neuraminidase-treated murine leukaemia cells.
Sethi KK; Brandis H
Eur J Cancer (1965); 1973; 9(11-12):809-19. PubMed ID: 4613554
[No Abstract] [Full Text] [Related]
10. On the surface structure of murine ascites tumors. I. Interactions with various phytoagglutinins.
Tomita M; Osawa T; Sakurai Y; Ukita T
Int J Cancer; 1970 Sep; 6(2):283-9. PubMed ID: 4320301
[No Abstract] [Full Text] [Related]
11. Tumour immunoprophylaxis exerted by the antimicrococcus immunity. I. Influence on the proliferation of murine leukaemic L1210 cells.
Verloes R; Atassi G; Dumont P; Kanarek L
Eur J Cancer (1965); 1978 Nov; 14(11):1203-12. PubMed ID: 738326
[No Abstract] [Full Text] [Related]
12. The electrophoretic changes of mammalian cells associated with malignant transformation.
Yamada T
Acta Pathol Jpn; 1972 Feb; 22(1):1-10. PubMed ID: 4341292
[No Abstract] [Full Text] [Related]
13. Presence and characterization of lymphokines in mouse ascites tumor fluids.
Zschiesche W; Fahlbusch B; Gutsche W
Int Arch Allergy Appl Immunol; 1976; 51(6):742-50. PubMed ID: 1002314
[TBL] [Abstract][Full Text] [Related]
14. Humoral reponse to neuraminidase-treated tumor cells.
Sansing WA; Kollmorgen GM
J Natl Cancer Inst; 1976 Jun; 56(6):1113-8. PubMed ID: 1032896
[TBL] [Abstract][Full Text] [Related]
15. The role of the BCG dose and the mouse strain in the inhibition of development of neoplasms susceptible and nonsusceptible to the action of natural cytotoxic cells.
Skórski T
Folia Histochem Cytobiol; 1985; 23(1-2):3-10. PubMed ID: 4043437
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.
Kataoka T; Oh-Hashi F; Sakurai Y
Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360
[TBL] [Abstract][Full Text] [Related]
17. Active immunotherapy in spontaneous leukemia of AkR mice.
Mathé G; Halle-Pannenko O; Bourut C
Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
[No Abstract] [Full Text] [Related]
18. Tumorigenicity and immunogenicity of somatic cell hybrids between L1210 mouse leukemia cell and L-fibroblast.
Watanabe E; Kawashima K; Isobe K; Yamada K; Saga S; Takahashi T
Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):121-9. PubMed ID: 6858561
[No Abstract] [Full Text] [Related]
19. Augmentation of the antibody forming cell response to neuraminidase-treated cells by myxoviruses.
Russell PH
Immunology; 1981 Dec; 44(4):781-7. PubMed ID: 6274794
[TBL] [Abstract][Full Text] [Related]
20. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
Sur P; Roy DK
Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
